The product is white to pale yellow power.
Indication: This product is used for infection due to gram-positive bacteria and mycoplasma. It mainly cure chicken chronic respiratory disease, swine toxoplasmosis, asthma, atrophic rhinitis, infectious pleuropneumonia, bacterial pneumonia, swine dysentery, necrotic enteritis, streptococcicosis etc.
Packing: 15kg/drum.
Features Specifications: Tylosin Tartrate
Tylosin tartrate ep4 powder (for injection & oral)
Tylosin tartrate bpv2001powder (for oral solution)
Tylosin tartrate bpv2001 granular (for oral solution)
Tylosin tartrate
Molecular formula. (c46h77no17)2c4h6o2
Molecular weight: 1998.31
CAS#: 74610-55-2
Appearance: Almost white to pale yellow powder
Tylosin a>90%,
Tylosin a+b+c+d>97%
Potency: Approx. 900-950iu/mg
Tylosin tartrate possesses the following characteristics in quality and appearance:
(1) composition a is above 90% (pharmacopoeia requires 80%), potency is above 900iu/mg (pharmacopoeia requires 800iu/mg), the curative effect improves completely.
(2) the content of tyramine and water is much more lower than requirements in pharmacopoeia.
(3) unit weight is light, degree of even-mixture is high
(4) quickly dissolved in water, high cleaning degree, not liable to be turbidity
Indication: This product is used for infection due to gram-positive bacteria and mycoplasma. It mainly cure chicken chronic respiratory disease, swine toxoplasmosis, asthma, atrophic rhinitis, infectious pleuropneumonia, bacterial pneumonia, swine dysentery, necrotic enteritis, streptococcicosis etc.
Packing: 15kg/drum.
Features Specifications: Tylosin Tartrate
Tylosin tartrate ep4 powder (for injection & oral)
Tylosin tartrate bpv2001powder (for oral solution)
Tylosin tartrate bpv2001 granular (for oral solution)
Tylosin tartrate
Molecular formula. (c46h77no17)2c4h6o2
Molecular weight: 1998.31
CAS#: 74610-55-2
Appearance: Almost white to pale yellow powder
Tylosin a>90%,
Tylosin a+b+c+d>97%
Potency: Approx. 900-950iu/mg
Tylosin tartrate possesses the following characteristics in quality and appearance:
(1) composition a is above 90% (pharmacopoeia requires 80%), potency is above 900iu/mg (pharmacopoeia requires 800iu/mg), the curative effect improves completely.
(2) the content of tyramine and water is much more lower than requirements in pharmacopoeia.
(3) unit weight is light, degree of even-mixture is high
(4) quickly dissolved in water, high cleaning degree, not liable to be turbidity

